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Letter 
Peritonitis Following Endoscopic Polypectomy in a Peritoneal Dialysis 
Patient: The Need for Antibiotic Prophylaxis 
Colonoscopy performed by an experienced endoscopist is a re- 
markably safe procedure. The incidence of perforation of the co- 
lon as a result of colonoscopy has been estimated to be between 
0.1-0.8% for diagnostic examinations and 0.5-3% for therapeu- 
tic procedures [1]. We report a patient, treated with peritoneal 
dialysis because of end-stage renal failure, who developed peri- 
tonitis following intestinal endoscopy and polypectomy. Perito- 
nitis is a major complication i patients treated with Continuous 
Ambulatory Peritoneal Dialysis (CAPD) [2]. It is caused mainly 
by bacteria from skin flora, entering the peritoneal cavity intralu- 
minally or extraluminally via the catheter tunnel. In addition, in- 
testinal perforation due to diverticulitis can cause severe peri- 
tonitis, necessitating laparotomy and removal of the catheter. In 
the last few years everal cases of endoscopy induced peritonitis 
in CAPD patients have been reported [3-7]. The pathophysio- 
logical mechanisms involved are discussed. We recommend pro- 
phylactic treatment with antibiotics for CAPD patients under- 
going intestinal endoscopy and polypectomy. 
A 51-year-old female patient had been maintained on Contin- 
uous Cyclic Peritoneal Dialysis, another modality of peritoneal 
dialysis, since 1990. In 1982 the patient started on chronic inter- 
mittent hemodialysis because of end stage renal disease second- 
ary to nephrolithiasis and recurrent pyelonephritis. She under- 
went kidney transplantation hree times. In May 1992 she devel- 
oped symptomatic anemia due to fecal blood loss. A colonoscopy 
was performed with an Olympus type Q20 after polyethylene 
glycol purgation. In the sigmoid both a sessile and a pedunculat- 
ed polyp with dimeters of 3-4 mm were removed with the hot 
biopsy forceps. Histologic examination revealed hyperplastic 
polyps. Within 12 h after the procedure the patient developed ab- 
dominal pains, fever and a cloudy dialysate outflow. The abdo- 
men was diffusely tender with rebound tenderness, but without 
abdominal muscle rigidity. Radiographic examination did not 
demonstrate free air in the abdomen. Dialysate cell counts how- 
ed an increased number of leukocytes (2.0 x 109/1) with 89% pol- 
ymorphonuclears (PMNs) at differential counting. A Gram 
stain of the fluid showed gram-negative rods. The patient was 
treated with intraperitoneal cefuroxime and tobramycin. The 
dialysate l ukocyte count returned to normal (< 0.1 x 109/1) with- 
in 3 days. After 5 days of treatment the leukocytes in the pe- 
ritoneal fluid rose again to 3.7 x 109 celts/1 on day6 and to 24.8 x 
109 cells/1 on day 7 with more than 80% PMNs at differential 
counting, with a concomitant increase in abdominal symptoms. 
Culture results of the peritoneal dialysate taken on the first day 
after colonoscopy showed three types of anaerobes (Peptostrep- 
tococcus asaccharolyticus, Bacteroides disiens and Bacteroides 
ureolyticus). On day 6 after colonoscopy Bacteroides disiens was 
cultured again from the dialysate. The antibiotics were changed 
to cefltroxime and metronidazole, administered intraperitoneal- 
ly and intravenously respectively. Within 7 days the dialysate l u- 
kocyte counts returned to normal again and abdominal symp- 
toms gradually disappeared. The antibiotic treatment was given 
for a period of 17 days. 
In view of the number of cases reported (Table 1) peritoneal dial- 
ysis patients would seem to have an increased risk of developing 
peritoneal infections following lower-intestinal endoscopy [3-7]. 
There is a number of potential reasons for this increased risk. 
Table 1: Peritonitis following colonoscopy in peritoneal dialysis 
patients. 
Petersen [3] Escherichia coli 
Holley [4] . Escherichia coli + 
Sprenger [5] Enterococcus + 
Ray [6] Bacteroides pp. + 
4 different species 
Verger [7] Escherichia coli + 
Bac Bacteroides spp. + 
2 different species 
Peptostreptococcus 
+# 
+* 
# Vancomycin a d gentamycin were given intravenously; * cephalothin 
was given intraperitoneally. 
First, the continuous exchange of dialysate in the peritoneal cav- 
ity results in dilution of both cellular and humeral components of
the host defense ystem, such as opsonins [8]. Secondly, the un- 
physiological composition of peritoneal dialysate, including low 
pH and high glucose content, may impair the function of phag- 
ocytic cells, thereby increasing the risk of infection [9, 10]. The 
presence of a foreign body (the peritoneal catheter) may also in- 
crease the risk of developing and maintaining peritoneal infec- 
tions. 
Theoretically, there are two different routes for bacteria to enter 
the peritoneal cavity during endoscopy. First, translocation of 
bacteria to mesenteric lymph nodes and the portal circulation 
may result in systemic bacteremia with subsequent peritoneal 
seeding, resulting in peritonitis. Ithas been shown that gram-neg- 
ative aerobic enteric bacteria translocate more efficiently from 
the gastro-intestinal tract han other bacteria, especially obligate 
anaerobes [11, 12]. It could be possible that colonoscopy predis- 
poses to bacterial translocation and subsequent hematogenic 
peritonitis. 
On the other hand colonoscopy itseff can result in serosal tears 
and asymptomatic microperforations re ulting in transmural mi- 
gration of the gut flora [1]. It is remarkable that in five of the six 
reported cases peritonitis occurred after polypectomy (Table 1). 
This procedure causes a local mucosal defect through which, un- 
der high pressure caused by the endoscope, intestinal flora can 
easily gain access to all layers of the colonic wall and pass through 
the serosa into the peritoneal cavity. In patients on CAPD, peri- 
tonitis could develop more easily due to the absence of local bac- 
tericidal and opsonic activity. In these cases, polymicrobial in- 
fections predominantly caused by anaerobic bacteria, as describ- 
ed in this case report, may be expected. 
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Preventative antibiotic therapy in patients maintained on perito- 
neal dialysis undergoing colonoscopy should be prescribed when 
polypectomy isanticipated. This prophylaxis should cover anaer- 
obic as well as gram-positive and gram-negativeenteric aerobic 
organisms. In view of the pathophysiological mechanisms dis- 
cussed above, one might consider drainingthe peritoneal cavity 
prior to intestinal endoscopy and leaving it empty for some time 
after the procedure. 
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References 
1. Kavin, H., Sinicrope, F., Esker, A. H.: Management of perforation of 
the colon at colonoscopy. Am. J. Gastroenterol. 87 (1992) 161-167. 
2. Nolph, K, D., Lindblad, A. S., Nowak, J. W.: Continuous ambulatory 
peritoneal dialysis. N. Engl. J. Med. 318 (1988) 1595-1599. 
3. Petersen, J. H., Weesner, R. E., GianneHa R. A.: Escherichia coli 
peritonitis after left-sided colonoscopy in a patient on continuous 
ambulatory peritoneal dialysis. Am. J. Gastroenterol. 82 (1987)
171-172. 
4. Holley, J., Seibert, D., Moss, A.: Peritonitis following colonoscopy 
and polypectomy: a need for prophylaxis? Perit. Dial. Bull. 7 (1987) 
105-106. 
5. Sprenger, R., Neyer, U.: Enterococcus-peritonitis after endoscopic 
polypectomy: need for prophylactic antibiotics. Petit. Dial. Bull. 7 
(1987) 263. 
6. Ray, S. M., Piraino, B., HoHey, J.: Peritonitis following colonoscopy 
in a peritoneal dialysis patient. Petit. Dial. Int. 10 (1990) 97-98. 
7. Verger, C., Danne, O., Vuillemin, F.: Colonoscopy and continuous 
ambulatory dialysis. Gastrointest. Endosc. 33 (1987) 334-335. 
8. Keane, W. F., Comfy, C. M., Verbrugh, H. A., Peterson, P. K.: 
Opsonic deficiency of peritoneal dialysis effluent in continuous am- 
buiatory peritoneal di ysis. Kidney Int. 25 (1984) 539-543. 
9. Van Bronswijk, H., Verburgh, H. A., Heezins, H. C. L. M.: Dialysis 
fluids and local host resistance in patients on co tinuous ambulatory 
peritoneal dialysis. Eur. J. Clin. Microbiol. Infect. Dis. 7 (1988) 
368-372. 
10. Duwe, A. K, Vas, S. I., Weatherhead, J. W.: Effects of the composi- 
tion of peritoneal dialysis fluid on chemiluminescence, phagocytosis, 
and bactericidal activity in vitro. Infect. Immun. 33 (1981) 30-135. 
11. Runyon, B. A.: Pathogenesis and diagnosis of sp ntaneous bacterial 
peritonitis. In: J. Rodes, V. Arroyo (eds.): Therapy in liver disease. 
Ediciones Doyma, Barcelona 1991, pp. 388-396. 
1.2. Steffen, E. K., Berg, R. D., Deitch, E. A.: Comparison Of transloca- 
tion rates of various indigenous bacteria fromthe gastrointestinal 
tract to the mesenteric lymph node. J. Infect. Dis. 157 (1988) 
1032-1038. 
Meetings 
14-18 August 1994 
Progress in Clinical Virology 
Stockholm, Sweden. Contact: Meetings Secretariat, Stock- 
holm Convention Bureau, Box 6911, S-102 39 Stockholm, 
Sweden. 
25-27 August 1994 
5th International Symposium on New Quinolones 
Singapore. Contact: The Symposium Secretariat, 336 Smith 
St., 06-302 New Bridge Centre, Singapore 0105. 
4-8 September 1994 
Conference of the Hospital Infection Society 
London, UK. Contact: Conference Associates and Ser- 
vices, Ltd., Congress House, 55 New Cavendish St., Lon- 
don, WIMTRE, UK. 
4-7 October 1994 
34th Interscience Conference on Antimicrobial Agents 
and Chemotherapy 
Orlando, FL, USA. Contact: Meetings Department. Amer- 
ican Society for Microbiology, 1325 Massachusetts Ave. 
NW, Washington, DC 20005-4171, USA. 
4-7 December 1994 
4th Western Pacific Congress of Chemotherapy and 
Infectious Diseases 
Manila, Philippines. Contact: Tropical Disease Founda- 
tion, Manahan Annex, Makati Medical Centre, 2 Amorso- 
1o St., Legaspi Village, Makati, Manila, Philippines. 
6-9 December 1994 
Second International Congress on the Management of In- 
fection 
Amsterdam, The Netherlands. Contact: Mr. James Arthur, 
Gardiner-Caldwell Communications Ltd., The Old Ribbon 
Mill, Pitt Street, Macclesfield, Cheshire SK l l  7PT, UK. 
Infection 22 (1994) No. 3 © MlVYV Medizin Verlag GmbH Miinchen, Manchen 1994 221 / 71 
